News
Vinay Prasad is once again head of the FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign ...
Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...
Vinay Prasad is back at the FDA, and in a position in which grappling with nuance — not always his strong suit — will be the ...
Vinay Prasad is once again head of the FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign ...
After exiting the FDA less than two weeks ago for unclear reasons, Vinay Prasad is once again director of the Center for ...
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results